We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.7B
AUM Growth
+$3.14B
Cap. Flow
+$1.47B
Cap. Flow %
7.1%
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$221M
2
GDDY icon
GoDaddy
GDDY
+$159M
3
CI icon
Cigna
CI
+$135M
4
PFE icon
Pfizer
PFE
+$132M
5
HOLX
Hologic
HOLX
+$98.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$156M
2
AAPL icon
Apple
AAPL
+$148M
3
MSFT icon
Microsoft
MSFT
+$126M
4
MCD icon
McDonald's
MCD
+$121M
5
DHR icon
Danaher
DHR
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 21.4%
3 Consumer Discretionary 12.43%
4 Industrials 11.77%
5 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
1051
IBM
IBM
$224B
$111K ﹤0.01%
+870
New +$113K
KIM icon
1052
Kimco Realty
KIM
$16.4B
$110K ﹤0.01%
+5,315
New +$112K
MBIN icon
1053
Merchants Bancorp
MBIN
$2.49B
$110K ﹤0.01%
8,336
-2,377
-22% -$27.7K
MOG.A icon
1054
Moog Inc Class A
MOG.A
$12.8B
$110K ﹤0.01%
+1,302
New +$111K
KL
1055
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$110K ﹤0.01%
+2,475
New +$110K
KHC icon
1056
Kraft Heinz
KHC
$30B
$107K ﹤0.01%
3,342
-738,046
-100% -$22.4M
VER
1057
DELISTED
VEREIT, Inc.
VER
$107K ﹤0.01%
2,320
-448,920
-99% -$21.5M
ORTX
1058
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$105K ﹤0.01%
+765
New +$93K
MUR icon
1059
Murphy Oil
MUR
$4.78B
$104K ﹤0.01%
+3,893
New +$89.3K
NHI icon
1060
National Health Investors
NHI
$3.65B
$103K ﹤0.01%
1,259
-276
-18% -$22.6K
LEG icon
1061
Leggett & Platt
LEG
$1.31B
$102K ﹤0.01%
+2,005
New +$98.3K
SITE icon
1062
SiteOne Landscape Supply
SITE
$4.53B
$102K ﹤0.01%
+1,123
New +$95.2K
NGVT icon
1063
Ingevity
NGVT
$2.68B
$100K ﹤0.01%
1,149
-19,025
-94% -$1.66M
INFY icon
1064
Infosys
INFY
$50.7B
$99K ﹤0.01%
9,538
-82,366
-90% -$829K
JNPR
1065
DELISTED
Juniper Networks
JNPR
$97K ﹤0.01%
3,922
-371,567
-99% -$9.14M
FTS icon
1066
Fortis
FTS
$28.7B
$96K ﹤0.01%
2,300
-6,800
-75% -$278K
GYRE icon
1067
Gyre Therapeutics
GYRE
$744M
$96K ﹤0.01%
+1,889
New +$79.2K
IIPR icon
1068
Innovative Industrial Properties
IIPR
$1.72B
$95K ﹤0.01%
+1,251
New +$97.1K
GTX icon
1069
Garrett Motion
GTX
$5.57B
$94K ﹤0.01%
9,417
+2,658
+39% +$27.1K
JOUT icon
1070
Johnson Outdoors
JOUT
$505M
$91K ﹤0.01%
+1,185
New +$77.5K
HVT icon
1071
Haverty Furniture Companies
HVT
$454M
$88K ﹤0.01%
+4,367
New +$88.2K
RFP
1072
DELISTED
Resolute Forest Products Inc.
RFP
$88K ﹤0.01%
20,928
+13,975
+201% +$58K
PRKS icon
1073
United Parks & Resorts
PRKS
$2.12B
$87K ﹤0.01%
2,721
-39,709
-94% -$1.15M
EEFT icon
1074
Euronet Worldwide
EEFT
$2.7B
$86K ﹤0.01%
+546
New +$82.4K
AGTC
1075
DELISTED
Applied Genetic Technologies Corporation
AGTC
$86K ﹤0.01%
19,048
+8,831
+86% +$27.9K
41 42
43
44 45

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.

  • Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
  • Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
  • Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
  • Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
  • Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
  • Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.